These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3322633

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams.
    Kresch MJ, Clive JM.
    J Perinatol; 1998; 18(4):276-83. PubMed ID: 9730197
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O, Kale G.
    Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life].
    Walti H, Relier JP, Huon C, Monset-Couchard M, Scemama M, De Gamarra E, Moriette G, Curstedt T, Robertson B.
    Arch Fr Pediatr; 1990 May; 47(5):329-34. PubMed ID: 2196030
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
    Claris O, Lapillonne A, Madinier-Chappat N, Miguet D, Salle BL.
    Cah Anesthesiol; 1994 May; 42(3):325-8. PubMed ID: 7812856
    [Abstract] [Full Text] [Related]

  • 10. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Rossello JD, Hayward PE, Martell M, Del Barco M, Margotto P, Grandzoto J, Bastida J, Peña J, Villanueva D.
    J Perinat Med; 1997 May; 25(3):280-7. PubMed ID: 9288665
    [Abstract] [Full Text] [Related]

  • 11. Surfactant treatment may accelerate epithelial cell regeneration in hyaline membrane disease of the newborn.
    Gonda TA, Hutchins GM.
    Am J Perinatol; 1998 May; 15(9):539-44. PubMed ID: 9890252
    [Abstract] [Full Text] [Related]

  • 12. Surfactant and respiratory distress syndrome.
    Milner AD.
    Turk J Pediatr; 1996 May; 38(1):37-43. PubMed ID: 8819619
    [Abstract] [Full Text] [Related]

  • 13. Endotracheal continuous positive airway pressure after rescue surfactant therapy.
    Mandy GT, Moïse AA, Smith EO, Hansen TN.
    J Perinatol; 1998 May; 18(6 Pt 1):444-8. PubMed ID: 9848758
    [Abstract] [Full Text] [Related]

  • 14. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D, Maeta H, Raju TN, John E, Bhat R, Go M, Dahiya U, Roberson Y, Yamin A, Narula A.
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [Abstract] [Full Text] [Related]

  • 15. [Pneumothorax in premature neonates with hyaline membrane disease: risk factors and consequences].
    Roeleveld-Versteegh AB, Groenendaal F.
    Tijdschr Kindergeneeskd; 1992 Dec; 60(6):221-5. PubMed ID: 1488734
    [Abstract] [Full Text] [Related]

  • 16. The era of pulmonary surfactant from Laplace to nowadays.
    Parmigiani S, Solari E.
    Acta Biomed; 2003 Aug; 74(2):69-75. PubMed ID: 14509914
    [Abstract] [Full Text] [Related]

  • 17. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U, Promwong N, Kanjanapattanakul W, Khorana M, Sangtawesin V, Horpaopan S.
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [Abstract] [Full Text] [Related]

  • 18. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA, American Academy of Pediatrics Committee on Fetus and Newborn.
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [Abstract] [Full Text] [Related]

  • 19. Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome.
    Donn SM, Dalton J.
    Respir Care; 2009 Sep; 54(9):1203-8. PubMed ID: 19712497
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hyaline membrane disease by human amniotic fluid surfactant.
    Jin HZ, Chen C, Jin QL, Shao XM.
    Chin Med J (Engl); 1989 Dec; 102(12):944-6. PubMed ID: 2517741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.